Medical Devices
Technology
Health

Masimo

$133.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.51 (0.38%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Masimo and other stocks, options, ETFs, and crypto commission-free!

About

Masimo Corporation Common Stock, also called Masimo, is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories. Read More The company was founded by Joe E. Kiani in May 1989 and is headquartered in Irvine, CA.

Employees
4,500
Headquarters
Irvine, California
Founded
1989
Market Cap
7.07B
Price-Earnings Ratio
38.66
Dividend Yield
0.00
Average Volume
479.31K
High Today
$134.90
Low Today
$132.31
Open Price
$133.05
Volume
79.01K
52 Week High
$135.75
52 Week Low
$83.16

Collections

Medical Devices
Technology
Health
Medical
Gas
Oil and Gas
Fossil Fuel
US

News

BusinessWireMar 19

St. Luke’s University Health Network Achieves Compelling Outcome Results Following Implementation of Masimo Supplemental Remote Monitoring Solution

BETHLEHEM, Pa.--(BUSINESS WIRE)--St. Luke’s University Health Network (St. Luke’s) and Masimo (NASDAQ: MASI) announced today that St. Luke’s, a regional network of 10 hospitals and 320 affiliated sites providing service to 10 counties in eastern Pennsylvania, is expanding their use of a variety of Masimo technologies following impressive outcome results at a pilot site.

10
Yahoo FinanceMar 15

Here's Why You Should Buy Masimo (MASI) Stock Right Now

Masimo Corporation MASI has been gaining investor confidence on continued positive results. Over the past year, the stock has rallied 54% compared with the industry’s 8% gain. Also, the company has outperformed the S&P 500’s 2.5% rally. The company has an encouraging earnings surprise history, having outpaced the Zacks Consensus Estimate in each of the trailing three quarters, the average being 4.3%. Notably, this trend of consecutive beats underlines its operating efficiency. A solid fourth-quarter show a...

112
TradingNewsNowMar 13

Current Trend: Masimo Corporation (NASDAQ: MASI)

Masimo Corporation is in the healthcare sector and is part of the medical instruments and equipment industry. The company CEO is Joseph E. Kiani. Masimo Corp is a medical technology company. The company develops, manufactures, and markets noninvasive monitoring technologies. Its product includes noninvasive blood constituent and brain and breath monitoring. Previous Intraday Trading Performance: The MASI stock showed a previous change of 0.70% with an open at 130.96 and a close of 131.84. It reached an in...

14

Earnings

$0.53
$0.63
$0.73
$0.83
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 1, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.